Stock Earnings

Question 1

What are Krystal Biotech Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Krystal Biotech Inc has a total asset of $1,055, Net profit of $89

Question 2

What are the key financial ratios for KRYS?

Accepted Answer

Krystal Biotech Inc's Current ratio is 9.67, has a Net margin is 30.68, sales per share of $9.75.

Question 3

How is Krystal Biotech Inc's revenue broken down by segment or geography?

Accepted Answer

Krystal Biotech Inc largest revenue segment is Genetic Medicines, at a revenue of 290,515,000 in the most earnings release.For geography, United States is the primary market for Krystal Biotech Inc, at a revenue of 290,515,000.

Question 4

Is Krystal Biotech Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Krystal Biotech Inc has a net profit of $89

Question 5

Does Krystal Biotech Inc have any liabilities?

Accepted Answer

yes, Krystal Biotech Inc has liability of 109

Question 6

How many outstanding shares for Krystal Biotech Inc?

Accepted Answer

Krystal Biotech Inc has a total outstanding shares of 28.79

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	359	290	50	0	0	0
Revenue Growth (YoY)	115.99%	480%	--	--	--	--
Cost of Revenue	23	20	3	--	--	--
Gross Profit	335	270	47	--	--	--
Selling, General & Admin	127	113	98	77	40	15
Research & Development	55	53	46	42	27	17
Operating Expenses	183	167	144	120	68	33
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	168	95	12	-139	-69	-32
Income Tax Expense	22	6	1	--	--	--
Net Income	146	89	10	-139	-69	-32
Net Income Growth	39%	790%	-107%	101%	115.99%	68%
Shares Outstanding (Diluted)	29.74	29.74	27.75	25.49	22.2	18.79
Shares Change (YoY)	0%	7%	9%	15%	18%	18%
EPS (Diluted)	4.91	2.99	0.39	-5.49	-3.13	-1.71
EPS Growth	38%	661%	-107%	75%	83%	43%
Free Cash Flow	185	119	-100	-153	-116	-40
Free Cash Flow Per Share	6.21	4	-3.6	-6	-5.22	-2.12
Gross Margin	93.31%	93.1%	94%	--	--	--
Operating Margin	42.06%	35.51%	-194%	0%	0%	0%
Profit Margin	40.66%	30.68%	20%	0%	0%	0%
Free Cash Flow Margin	51.53%	41.03%	-200%	0%	0%	0%
EBITDA	156	108	-92	-116	-66	-32
EBITDA Margin	43.45%	37.24%	-184%	0%	0%	0%
D&A For EBITDA	5	5	5	4	2	1
EBIT	151	103	-97	-120	-68	-33
EBIT Margin	42.06%	35.51%	-194%	0%	0%	0%
Effective Tax Rate	13.09%	6.31%	8.33%	--	--	--

Krystal Biotech Inc (KRYS) Price

KRYS Stock Price Chart

KRYS Income

Follow-Up Questions